[
  {
    "ts": "2025-11-26T08:00:00+00:00",
    "headline": "Nasdaq AxiomSL Expands RegTech Deployment with Revolut, Accelerating Global Growth",
    "summary": "Integrated regulatory reporting and risk platform to support Revolut’s expanding global footprintLONDON and NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nasdaq today announced a significant expansion of its strategic regulatory technology partnership with global fintech Revolut. The partnership centers on the deployment of Nasdaq AxiomSL, a regulatory reporting and risk platform used by 90% of global systemically important banks (G-SIBs) to comply with domestic and international regulatory obliga",
    "url": "https://finance.yahoo.com/news/nasdaq-axiomsl-expands-regtech-deployment-080000621.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "34419702-94b5-3d77-a3fd-e6fba773210a",
      "content": {
        "id": "34419702-94b5-3d77-a3fd-e6fba773210a",
        "contentType": "STORY",
        "title": "Nasdaq AxiomSL Expands RegTech Deployment with Revolut, Accelerating Global Growth",
        "description": "",
        "summary": "Integrated regulatory reporting and risk platform to support Revolut’s expanding global footprintLONDON and NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nasdaq today announced a significant expansion of its strategic regulatory technology partnership with global fintech Revolut. The partnership centers on the deployment of Nasdaq AxiomSL, a regulatory reporting and risk platform used by 90% of global systemically important banks (G-SIBs) to comply with domestic and international regulatory obliga",
        "pubDate": "2025-11-26T08:00:00Z",
        "displayTime": "2025-11-26T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/c870662b5d8053bb2dfb7f7795f63c9c",
          "originalWidth": 150,
          "originalHeight": 43,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IvDiuYFpIAPCtlMyS0XrDg--~B/aD00Mzt3PTE1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c870662b5d8053bb2dfb7f7795f63c9c.cf.webp",
              "width": 150,
              "height": 43,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R6.ILk2v2HeNDoQE69FyUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c870662b5d8053bb2dfb7f7795f63c9c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nasdaq-axiomsl-expands-regtech-deployment-080000621.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nasdaq-axiomsl-expands-regtech-deployment-080000621.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NDAQ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T12:00:00+00:00",
    "headline": "Nasdaq Halts Charming Medical Limited",
    "summary": "NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company’s ordinary shares was $29.355. More information about the SEC’s order can be found at https:",
    "url": "https://finance.yahoo.com/news/nasdaq-halts-charming-medical-limited-120000308.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "6e7f17fb-3075-3f55-a50c-aea1db239051",
      "content": {
        "id": "6e7f17fb-3075-3f55-a50c-aea1db239051",
        "contentType": "STORY",
        "title": "Nasdaq Halts Charming Medical Limited",
        "description": "",
        "summary": "NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company’s ordinary shares was $29.355. More information about the SEC’s order can be found at https:",
        "pubDate": "2025-11-26T12:00:00Z",
        "displayTime": "2025-11-26T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/c870662b5d8053bb2dfb7f7795f63c9c",
          "originalWidth": 150,
          "originalHeight": 43,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IvDiuYFpIAPCtlMyS0XrDg--~B/aD00Mzt3PTE1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c870662b5d8053bb2dfb7f7795f63c9c.cf.webp",
              "width": 150,
              "height": 43,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R6.ILk2v2HeNDoQE69FyUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c870662b5d8053bb2dfb7f7795f63c9c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nasdaq-halts-charming-medical-limited-120000308.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nasdaq-halts-charming-medical-limited-120000308.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCTA"
            },
            {
              "symbol": "NDAQ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]